strategic collaboration

Following disappointing announcements this week concerning the unmet primary endpoints of their Phase III trials, Merck and AstraZeneca have today revealed they are entering a strategic oncology collaboration. more

27 Jul 2017 11:50 News

Biopharmaceutical company, Ablynx, and Sanofi have entered into a strategic collaboration for the development of Nanobody based therapeutics for the treatment of immune-mediated inflammatory diseases. more

20 Jul 2017 12:22 News

Exscientia and GlaxoSmithKline (GSK) have entered into a strategic collaboration to apply an AI-enabled platform in the discovery of novel and selective small molecules for up to 10 disease-related targets. more

5 Jul 2017 12:13 News